News from NYU Langone Health
NYU Langone and NYU Grossman in the News
Kids get diseases like lupus, too. As researchers hunt better treatments, this camp brings joy
Associated Press
Research at NYU Langone Health is studying how to prevent a rare fetal heart defect in babies born to mothers with autoimmune diseases like lupus. The study, led by Jill P. Buyon, MD, director of the Division of Rheumatology and the Sir Deryck and Lady Va Maughan Professor of Rheumatology at NYU Langone Health, is testing if a drug can block antibodies from crossing the placenta during key cardiac development. Philip M. Carlucci, MD, assistant professor in the Department of Medicine at NYU Langone Health, is a co-author. The team recently reported a healthy baby born to a mother who received the experimental treatment. The NIH will fund a clinical trial for other high-risk pregnancies.
Also reporting was: Independent Journal Review
11/18/2025
Barriers exist in underuse of treatment intensification in advanced prostate cancer
HemOnc Today
Oncologists and urologists have identified numerous barriers to treatment intensification for metastatic castration-sensitive prostate cancer, including knowledge gaps and costs. In an interview, Stacy Loeb, MD, professor in the Departments of Urology and Population Health at NYU Langone Health, explained that every effort should be made to eliminate these barriers. Dr. Loeb noted that the study also identified 14 facilitators, such as good knowledge of clinical trial data and strong interdisciplinary collaborations. The research suggested cross-specialty tumor boards as a potential intervention to improve uptake of guideline-concordant care.
11/18/2025
A silent kidney crisis is spreading faster than anyone expected
WDC TV News
A new analysis co-led by researchers from NYU Langone Health reveals a growing global kidney crisis, with the number of people with reduced kidney function rising to 788 million in 2023. The study, published in The Lancet, lists chronic kidney disease among the top 10 causes of death worldwide. Study co-senior author Josef Coresh, MD, PhD, director of NYU Langone’s Optimal Aging Institute and the Terry and Mel Karmazin Professor of Population Health at the NYU Grossman School of Medicine, called it a major public health issue. Co-lead author Morgan Grams, MD, PhD, the Susan and Morris Mark Professor of Medicine at the NYU Grossman School of Medicine, highlighted the need for more testing and treatment access.
Also reporting was: Archynetys, GB News, Archyde, ScienceDaily
11/18/2025
Single-port robotic surgery advances cancer treatment
Industrial News UK
Single-port (SP) robotic surgery at NYU Langone Hospital—Long Island is advancing cancer treatment, as shown by the successful procedure on patient Joy Monetti. Anthony Corcoran, MD, director of urologic oncology at NYU Langone Hospital—Long Island and member of Perlmutter Cancer Center, used the technology to remove a kidney mass, resulting in a rapid recovery. The minimally invasive technique allows surgeons to operate through a single incision. Tara Martinez, DO, quality officer, Department of Surgery at NYU Langone Hospital-Suffolk, one of only two surgeons in New York certified for colorectal SP procedures, also uses the technology for various conditions, noting its precision.
11/18/2025
Reflex for stabilizing vision develops without sensory input
Optometry Times
A study in Science found that the vestibulo-ocular reflex, which stabilizes vision, develops without sensory input in newborns. This contrasts with adult vertebrates where the circuit is tuned by feedback. David Schoppik, PhD, associate professor in the Department of Otolaryngology—Head and Neck Surgery, the Department of Neuroscience and Physiology, and the Neuroscience Institute at NYU Langone Health, was the study's senior author. Using larval zebrafish, his team found that the reflex's development was comparable in blind and sighted subjects. The research suggests the neuromuscular junction's maturation, not sensory experience, determines the rate of maturation for this behavior.
11/18/2025
NYU Langone finds drug to combat congenital heart block in newborns
Washington Square News
Researchers at NYU Langone Health identified a drug, rozanolixizumab, as the first effective preventative therapy for congenital heart block in newborns. The rare disorder is caused by harmful antibodies passed from mother to fetus. A preliminary study found the antibody inhibitor prevented these antibodies from reaching the fetus. Philip M. Carlucci, MD, fellow in the Division of Rheumatology and Judith and Stewart Colton Center for Autoimmunity Breidenbach Scholar in the Department of Medicine at NYU Grossman School of Medicine, noted the therapy's importance for the highly fatal condition. The successful study has inspired a new multicenter trial to further investigate the treatment.
11/18/2025
NYU Langone study maps how neurons stabilize memories
Washington Square News
Researchers at NYU Langone Health identified neural connections that stabilize memories by linking sensory details to locations. The study, which observed mice, focused on pathways from the lateral entorhinal cortex to the hippocampus's CA3 region. The findings show that integrating more sensory information strengthens these pathways, making memories more accurate. According to study author Jayeeta Basu, PhD, assistant professor of Psychiatry and Neuroscience and a faculty member at the Institute for Translational Neuroscience at NYU Langone Health, the research has implications for understanding memory disorders like Alzheimer's, schizophrenia, and PTSD, providing a foundation for studying how these circuits are impacted in pathological conditions.
11/18/2025
OncLive
The FDA has approved lurbinectedin plus atezolizumab as a first-line maintenance therapy for patients with extensive-stage small cell lung cancer. In an interview, Joshua K. Sabari, MD, an assistant professor in the Department of Medicine at NYU Grossman School of Medicine and director of High Reliability Organization Initiatives at the Perlmutter Cancer Center, called the approach practice-changing. The approval was supported by the IMforte trial, which demonstrated significant improvements in both progression-free and overall survival. Dr. Sabari noted the regimen expands a limited therapeutic arsenal but advised careful patient selection due to potential hematologic toxicity.
11/18/2025
NYU Langone ER department doctor gives tips for a safe Thanksgiving
WKBW-TV (Buffalo, NY)
According to Reed Caldwell, MD, associate professor, Ronald O. Perelman Department of Emergency Medicine, medical director, Emergency Medical Services, NYU Langone Health, rooms see a full range of holiday-related injuries and illnesses on Thanksgiving. He specifically highlights lacerations from sharp objects used during cooking and shopping. He also warns of injuries to the feet, as many cooks prepare their feast in socks or bare feet and can be burned by dropped hot dishes. The segment further advises using sharp knives to prevent slippage and properly smothering kitchen fires instead of using water.
11/18/2025
The Hair Report: Expert Perspectives on Hair Disorders in Skin of Color
Dermatology Times
During the 8th Annual Skin of Color Society’s media day, Prince Adotama, MD, assistant professor in The Ronald O. Perelman Department of Dermatology at NYU Grossman School of Medicine, assistant program director, Dermatology Residency Program, delivered a session on hair disorders. Dr. Adotama discussed androgenetic alopecia, emphasizing the importance of early and aggressive treatment to prevent progression. He covered therapies like topical minoxidil, finasteride, platelet-rich plasma, and hair transplantation. The presentation also explored other conditions like alopecia areata and central centrifugal cicatricial alopecia, highlighting the need for accurate diagnosis and culturally sensitive care for patients with skin of color.
11/18/2025
Global Leaders Driving The Future Of Healthcare At The 2025 Forbes Healthcare Summit
Forbes
The 14th Annual Forbes Healthcare Summit will be held on December 4 in New York City, with NYU Langone Health serving as the title sponsor. The event, themed 'The Patient Care Revolution,' will feature several leaders from the institution as confirmed speakers. These include Alec C. Kimmelman, MD, PhD, dean of NYU Grossman School of Medicine and chief executive officer of NYU Langone Health; Oren Cahlon, MD, executive vice president and vice dean for Clinical Affairs and Strategy, chief clinical officer, NYU Langone Health and Robert Montgomery, MD, DPhil, the H. Leon Pachter, MD, Professor of Surgery, chair, Department of Surgery, and director of the NYU Langone Transplant Institute.
11/18/2025
How to Attend Medical School for Free
U.S. News and World Report
An article examines the high cost of medical school and various pathways to attend for free, such as tuition-free programs and scholarships. It highlights the NYU Grossman School of Medicine as a key example, noting it offers full-tuition scholarships to all M.D. students, saving them $64,250 annually. The school also covers health insurance costs for students who maintain satisfactory academic progress. The piece also discusses programs at Kaiser Permanente Bernard J. Tyson School of Medicine, the Albert Einstein College of Medicine, and others that aim to reduce student debt.
11/18/2025
8 health systems restore telehealth access after shutdown
Becker's Hospital Review
Several health systems have restored telehealth access for Medicare patients after a temporary government funding bill passed on 12 November 2025. New York City-based NYU Langone Health announced that its telehealth services are fully restored and it is scheduling visits for eligible patients. The bill extended Medicare and Medicaid telehealth coverage through 30 January 2026. Other health systems that have also restarted Medicare telehealth include CommonSpirit Health, Novant Health, Nebraska Medicine, Providence, Scripps Health, Main Line Health, and St. Elizabeth Healthcare.
11/18/2025
Denying Prenatal Care to Unmarried Woman 'Morally Repugnant'
Medscape
In a commentary, Art Caplan, PhD, the Drs. William F. and Virginia Connolly Mitty Professor of Bioethics at NYU Grossman School of Medicine, discusses a Tennessee law that allows healthcare providers to refuse services that violate their conscience. He critiques a physician who used the law to deny prenatal care to an unmarried woman, calling the action 'morally repugnant.' Caplan argues that while physicians can decline to perform specific procedures they object to, they should not discriminate against or reject patients based on their personal characteristics or values, especially when it compromises necessary care for both the mother and unborn child.
11/18/2025
Ears Hurt After a Run? You’re Not Alone—Here’s Why It Happens
Peloton
Ear pain during or after running can be caused by several factors, including exposure to cold and wind, which constricts blood vessels in the sensitive ear canal. According to Lauren E. Borowski, MD, assistant professor, Department of Orthopedic Surgery and director, Primary Care Sports Medicine Fellowship Program, the body also diverts blood flow away from the ears to working muscles during exercise, which can exacerbate pain. Other potential causes include a clenched jaw, ill-fitting headphones, or referred pain from sickness, allergies, or sinus infections. Simple solutions like wearing a headband or changing headphones can help.
11/18/2025
Scientists Reverse Human Rejection of Pig Organ Transplant for First Time Ever
Smithsonian Magazine
A new study published in Nature details how an international team of physicians successfully reversed the rejection of a pig kidney transplant in a human recipient twice. The research was led by Robert Montgomery, MD, DPhil, director of the NYU Langone Transplant Institute, where the 61-day experiment was conducted on a brain-dead patient. By closely monitoring the patient, the team identified specific cells causing rejection and reversed it with existing medication. This marks the longest a pig organ has survived in a human recipient, offering hope that gene-edited pig organs could become a viable alternative for transplants.
11/18/2025
The Miracles Among Us: How God’s Grace Plays a Role in Healing
Mark Levin Podcast
Marc Siegel, MD, clinical professor of medicine and clinical coordinator of NYU Langone Health's SiriusXM Doctor Radio, and Fox News Senior Medical Analyst, has authored a new book, 'The Miracles Among Us: How God’s Grace Plays a Role in Healing.' Drawing from his experience as a physician, the book is a collection of true stories exploring the intersection of faith and medicine. It features narratives of patients who experienced remarkable recoveries that challenge the boundaries of medical science, highlighting inexplicable moments of healing and suggesting the role of a higher power.
11/18/2025
Energy Central
A paper in the journal Neuron argues there is no good evidence for a link between gut microbes and autism, criticizing growing research funding in this area from organizations like Wellcome Leap. The paper's authors state that evidence from human studies, mice research, and clinical trials remains weak. Kara Gross Margolis, MD, associate professor in the Department of Pediatrics at NYU Langone Health, states that it is indisputable that people with autism have much higher levels of gastrointestinal disorders and it is important to understand why. Researchers agree more study is needed.
11/18/2025
